Chabiotech Co.,Ltd. Statistics

Total Valuation

Chabiotech Co.,Ltd. has a market cap or net worth of KRW 831.77 billion. The enterprise value is 1.66 trillion.

Market Cap	831.77B
Enterprise Value	1.66T

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Chabiotech Co.,Ltd. has 55.97 million shares outstanding. The number of shares has decreased by -0.38% in one year.

Current Share Class	n/a
Shares Outstanding	55.97M
Shares Change (YoY)	-0.38%
Shares Change (QoQ)	-10.44%
Owned by Insiders (%)	15.89%
Owned by Institutions (%)	12.18%
Float	41.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.82
PB Ratio	2.50
P/TBV Ratio	9.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 86.86, with an EV/FCF ratio of -15.35.

EV / Earnings	-637.84
EV / Sales	1.64
EV / EBITDA	86.86
EV / EBIT	n/a
EV / FCF	-15.35

Financial Position

The company has a current ratio of 0.70, with a Debt / Equity ratio of 0.87.

Current Ratio	0.70
Quick Ratio	0.61
Debt / Equity	0.87
Debt / EBITDA	379.43
Debt / FCF	-6.19
Interest Coverage	-1.19

Financial Efficiency

Return on equity (ROE) is -1.02% and return on invested capital (ROIC) is -1.83%.

Return on Equity (ROE)	-1.02%
Return on Assets (ROA)	-1.25%
Return on Capital (ROIC)	-1.83%
Revenue Per Employee	3.46B
Profits Per Employee	-8.91M
Employee Count	292
Asset Turnover	0.53
Inventory Turnover	21.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-20.54%
50-Day Moving Average	15,987.80
200-Day Moving Average	16,735.00
Relative Strength Index (RSI)	45.00
Average Volume (20 Days)	199,452

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chabiotech Co.,Ltd. had revenue of KRW 1.01 trillion and -2.60 billion in losses. Loss per share was -214.79.

Revenue	1.01T
Gross Profit	260.17B
Operating Income	-38.25B
Pretax Income	-4.91B
Net Income	-2.60B
EBITDA	1.76B
EBIT	-38.25B
Loss Per Share	-214.79

Full Income Statement

Balance Sheet

The company has 276.77 billion in cash and 669.03 billion in debt, giving a net cash position of -392.27 billion or -7,008.07 per share.

Cash & Cash Equivalents	276.77B
Total Debt	669.03B
Net Cash	-392.27B
Net Cash Per Share	-7,008.07
Equity (Book Value)	768.80B
Book Value Per Share	5,952.41
Working Capital	-284.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.01 billion and capital expenditures -98.12 billion, giving a free cash flow of -108.13 billion.

Operating Cash Flow	-10.01B
Capital Expenditures	-98.12B
Free Cash Flow	-108.13B
FCF Per Share	-1,931.75

Full Cash Flow Statement

Margins

Gross margin is 25.76%, with operating and profit margins of -3.79% and -0.26%.

Gross Margin	25.76%
Operating Margin	-3.79%
Pretax Margin	-0.49%
Profit Margin	-0.26%
EBITDA Margin	0.17%
EBIT Margin	-3.79%
FCF Margin	n/a

Dividends & Yields

Chabiotech Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.38%
Shareholder Yield	0.38%
Earnings Yield	-1.45%
FCF Yield	-13.00%

Stock Splits

The last stock split was on June 2, 2014. It was a reverse split with a ratio of 0.7262.

Last Split Date	Jun 2, 2014
Split Type	Reverse
Split Ratio	0.7262

Scores

Chabiotech Co.,Ltd. has an Altman Z-Score of 0.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	n/a